Literature DB >> 16040397

Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells.

T Fehm1, E F Solomayer, S Meng, T Tucker, N Lane, J Wang, G Gebauer.   

Abstract

Novel assay methods developed for the isolation and characterization of circulating tumor cells (CTC) of epithelial origin offer the potential of markers for the non-invasive gathering of clinical information relevant to the diagnosis, evolution and treatment of carcinoma. Of the numerous techniques currently used to analyze CTC, slide-based assays are perhaps the most common. While traditional combined immunocytochemical/brightfield microscopy systems continue to be the most frequently employed, fluorescence-based analysis is gaining in importance. This is partly because fluorescence microscopy analysis of slide-mounted CTC can provide simultaneously cytogenetic as well as morphologic and multiple phenotypic information. In particular, fluorescence microscopy analysis of slide-mounted CTC can accurately determine genetic changes at the chromosomal level in patients with recurrent disease. More importantly, by identifying genetic aberrations in CTC, it becomes possible to choose those patients most likely to benefit from a given treatment. The potential of this technique has already been demonstrated by employing fluorescence in situ hybridization (FISH) methods to measure expression of the HER2/neu gene in tissue from patients with breast carcinoma for the specific purpose of identifying those patients most likely to respond to Trastuzumab targeted therapy. Here, we review the major methodologies used in the preparation and analysis of the slide-based assays.

Entities:  

Mesh:

Year:  2005        PMID: 16040397     DOI: 10.1080/14653240510027082

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  29 in total

1.  Molecular profiling of individual tumor cells by hyperspectral microscopic imaging.

Authors:  Jonathan W Uhr; Michael L Huebschman; Eugene P Frenkel; Nancy L Lane; Raheela Ashfaq; Huaying Liu; Dipen R Rana; Lawrence Cheng; Alice T Lin; Gareth A Hughes; Xiaojing J Zhang; Harold R Garner
Journal:  Transl Res       Date:  2011-09-03       Impact factor: 7.012

Review 2.  CTC enumeration and characterization: moving toward personalized medicine.

Authors:  Angela Toss; Zhaomei Mu; Sandra Fernandez; Massimo Cristofanilli
Journal:  Ann Transl Med       Date:  2014-11

Review 3.  Circulating Tumor Cells in Early-Stage Breast Cancer.

Authors:  A D Hartkopf; M Banys; N Krawczyk; M Wallwiener; H Schneck; H Neubauer; T Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

4.  Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker.

Authors:  Chuanli Ren; Chongxu Han; Daxin Wang; Xiaohang Zhao; Guangfu Jin; Hongbing Shen
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

Review 5.  Circulating tumors cells as biomarkers: progress toward biomarker qualification.

Authors:  Daniel C Danila; Klaus Pantel; Martin Fleisher; Howard I Scher
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

Review 6.  Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo.

Authors:  Jin-Woo Kim; Ekaterina I Galanzha; David A Zaharoff; Robert J Griffin; Vladimir P Zharov
Journal:  Mol Pharm       Date:  2013-02-25       Impact factor: 4.939

7.  Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics.

Authors:  Majid Ebrahimi Warkiani; Bee Luan Khoo; Lidan Wu; Andy Kah Ping Tay; Ali Asgar S Bhagat; Jongyoon Han; Chwee Teck Lim
Journal:  Nat Protoc       Date:  2015-12-17       Impact factor: 13.491

8.  Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.

Authors:  C Matuschek; Edwin Bölke; G Lammering; P A Gerber; M Peiper; W Budach; H Taskin; H B Prisack; G Schieren; K Orth; H Bojar
Journal:  Eur J Med Res       Date:  2010       Impact factor: 2.175

9.  A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

Authors:  Nadia Saucedo-Zeni; Steffi Mewes; Robert Niestroj; Lukasz Gasiorowski; David Murawa; Piotr Nowaczyk; Tatiana Tomasi; Ekkehard Weber; Grzegorz Dworacki; Nils G Morgenthaler; Heike Jansen; Corinna Propping; Karolina Sterzynska; Wojciech Dyszkiewicz; Maciej Zabel; Marion Kiechle; Ute Reuning; Manfred Schmitt; Klaus Lücke
Journal:  Int J Oncol       Date:  2012-07-16       Impact factor: 5.650

10.  Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage.

Authors:  Ada Gjyrezi; Giuseppe Galletti; Jiaren Zhang; Daniel Worroll; Michael Sigouros; Seaho Kim; Victoria Cooley; Karla V Ballman; Allyson J Ocean; Manish A Shah; Joseph M Scandura; Andrea Sboner; David M Nanus; Himisha Beltran; Scott Tagawa; Paraskevi Giannakakou
Journal:  Commun Biol       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.